High expression and oncogenic functions of EphA3 have been reported in acute lymphoblastic leukemia (ALL) [16], glioblastoma [17], gastric cancer [18], head and neck cancer [19], and prostate cancer [20]. This evidence concerns the gene EPHA3 and acute lymphoblastic leukemia.